Navigation Links
New technique reinforces immune cells that seek and destroy cancer, says Stanford researcher
Date:4/26/2010

be able to support themselves rather than relying on other immune cells perhaps a bit like Robocop and to insert the ability to switch that self-support on or off, to ensure that they don't grow out of control. That way, the T cells can persist in fighting the disease without becoming a cancer themselves.

Biologically speaking, T cells will only thrive in the presence of certain chemicals called cytokines that are normally delivered or triggered by other cells that are part of a proper immune response. In its work, the team implanted genes in the T cells, enabling the cells to produce the cytokines for themselves. This ability, however, is controlled by another addition: a series of switches, encoded in RNA, that allow cytokine production to proceed only in the presence of a drug.

With the help of co-author Michael Jensen, MD, cancer immunology researcher at the City of Hope's Beckman Research Institute in Duarte, Calif., the team tested a variety of modifications both in mice and in cultures of human T cells. They used different drugs to trigger the production of different cytokines. Generally, the results showed that their engineering produced healthier, faster-growing populations of the T cells, until the drugs were withdrawn and growth shut down. In the human cell cultures, for example, the technology led to a 24 percent increase in the live T-cell population compared to controls and 50 percent fewer cells dying off.

Synthetic biology

The research can be traced back to 2007 at Caltech, when Smolke led the development of the ribozyme-based RNA switches. At the time the switches were synthesized as fundamental, generally useful components. Now they have found an advanced use. By analogy, they are light switches that have now been successfully integrated into a working circuit.

"Originally we were looking at how can you design an RNA molecule that can detect a chemical and then translate that into a gene-regula
'/>"/>

Contact: David Orenstein
davidjo@stanford.edu
650-736-2245
Stanford University Medical Center
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. Researchers gain detailed insight into failing heart cells using new nano technique
2. Single-step technique produces both p-type and n-type doping for future graphene devices
3. New lab-on-a-chip technique developed at U of T
4. Leading Cardiovascular Surgeons Gather from Around the World to Share Ross Procedure Survival Data, Techniques at 2nd Annual Summit
5. Graphitic memory techniques advance at Rice
6. Single-molecule technique captures calcium sensor calmodulin in action
7. New MRI technique could mean fewer breast biopsies in high-risk women
8. New statistical technique improves precision of nanotechnology data
9. Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma
10. Secret of sandcastle construction could help revive ancient building technique, researchers say
11. Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 17, 2014 Gene synthesis and ... has entered into a technology access and services ... apply DNA2.0’s proprietary protein engineering technology, known as ... “We are extremely excited that the global leader ... This proprietary bioengineering technology has now been validated ...
(Date:12/17/2014)... -- Vermillion, Inc. (NASDAQ: VRML ), a bio-analytic ... next step in its expanded strategy to rebuild the ... naming of current Chief Operating Officer, Valerie Palmieri ... Chairman of the Board and CEO James LaFrance ... are effective January 1, 2015. "Jim and ...
(Date:12/17/2014)... 17, 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... acquisition, development and commercialization of innovative therapeutics addressing cancer ... with a primary commercial focus on China ... a Type C meeting with the U.S. Food and ... held in February 2015.  During this meeting the Company ...
(Date:12/17/2014)... 2014   Synageva BioPharma Corp. (NASDAQ: ... for rare disorders, announced today its presentation at the ... San Francisco, CA. ... will present on Monday, January 12, 2015, at 9:00 ... webcast live and may be accessed from the "Webcasts ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5
... Increases to 41% and Median Overall Survival Reported at 25 ... 7 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; ... endocrine therapy and oncology, today announced that its partner Keryx ... data as well as new survival data on the clinical ...
... , RESEARCH TRIANGLE PARK, N.C., Dec. 7 CeNeRx BioPharma, ... the central nervous system, today announced that a newly published PET ... TriRima (TM) reversibly inhibits MAO-A (monoamine oxidase A), an enzyme in ... mood. TriRima is a member of a new ...
... , ... (NYSE: WX ), a,leading pharmaceutical, biotechnology and ... China and the United States,announced today it has purchased ... 555 acoustic liquid handler for its work in high-,throughput ...
Cached Biology Technology:AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 2Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 3Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 4WuXi PharmaTech Selects Labcyte POD(TM) 810 Platform for High-Throughput Screening 2
(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader ... is seeing a staggering demand from its licensees for ... Company revealed, is not solely coming from fitness and ... well. "A wearable is only as useful ... accuracy is the ultimate driver in long-term mass consumer ...
(Date:12/10/2014)... California , December 9, 2014 ... with ITN,s BCARD Platform   ... cloud-based enterprise meeting scheduling solutions for business-to-business (B2B) ... the world leader in mobile near-field communication (NFC), ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , ...
(Date:12/3/2014)... IRVINE, Calif. , Dec. 2, 2014 /PRNewswire/ ... of globally deployed, innovative test solutions for military, ... the newest version of its successful TS-900 ... the performance and features of high-end systems to ... with outstanding value compared to traditional ATE. ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... of birds reproduce not by rearing their own young, but ... Known as brood parasitism, this habit has been most thoroughly ... the nests of martins and swallows in Europe are rarely ... the Hainan Normal University in China and his colleagues suggests ...
... research team has identified seven new gene loci linked to obesity. ... cause extreme obesity are similar to those that cause milder forms ... people were included in the study of the links between genes ... Nature Genetics . The aim of the study was to ...
... 2013, Cleveland: A compound abundant in red meat and added ... to promote atherosclerosis or the hardening or clogging of ... this week in the journal Nature Medicine . ... digestive tract metabolize the compound carnitine, turning it into trimethylamine-N-oxide ...
Cached Biology News:Birds find ways to avoid raising cuckoos' young 2Genes behind obesity mapped in large-scale study 2Cleveland Clinic researchers discover new link between heart disease and red meat 2Cleveland Clinic researchers discover new link between heart disease and red meat 3
45° Fixed Angle Rotor for use in the IEC Centra CL2, Centra CL3/CL3R, HN-SII, and the Centra-MP4/MP4R....
... The Lambda 10-2 is a microprocessor ... impressive speed coupled with exceptionally smooth ... for research applications involving fluorescence microscopy, ... any application requiring rapid and accurate ...
... FL is equipped with ... measurement technologies that complement ... advanced features of Fluoroskan ... Fluoroskan Ascent FL provides ...
... an enzyme that catalyzes the hydrolysis ... maltotriose, and dextrins. The,level of a-amylase ... body is of,clinical significance in the ... diabetes; plant and microbial a-amylases are,important ...
Biology Products: